Free tool
Cell therapy stocks
We cover 2 companies grouped under the Cell therapy theme. The median market value in the group is $32.57M. Across the group, the median move over the past trading day is +2.13%. Price change over the past year runs from −82.1% to −30.8% across the middle 80 percent of the group, with a median of −56.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
2 of 86 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| 4584.T | Kidswell Bio Corporation | 180.00 JPY | +28.57% | −15.09% | −24.37% |
| FBLG | FibroBiologics, Inc. | $1.40 | +123.29% | −70.83% | −88.54% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.